Oklahoma 2024 Regular Session

Oklahoma House Bill HB2351 Compare Versions

OldNewDifferences
11
22
3-ENGR. H. B. NO. 2351 Page 1 1
3+HB2351 HFLR Page 1
4+BOLD FACE denotes Committee Amen dments. 1
45 2
56 3
67 4
78 5
89 6
910 7
1011 8
1112 9
1213 10
1314 11
1415 12
1516 13
1617 14
1718 15
1819 16
1920 17
2021 18
2122 19
2223 20
2324 21
2425 22
2526 23
2627 24
2728
28-ENGROSSED HOUSE
29-BILL NO. 2351 By: Dempsey and Davis of the
30-House
29+HOUSE OF REPRESENTATIVES - FLOOR VERSION
3130
32- and
31+STATE OF OKLAHOMA
3332
34- Hicks of the Senate
33+1st Session of the 59th Legislature (2023)
34+
35+HOUSE BILL 2351 By: Dempsey
3536
3637
3738
3839
3940
40-[ health insurance - treatment of diabetes - program
41-that allows Oklahomans to purchase discounted
42-insulin – codification - effective date ]
41+AS INTRODUCED
42+
43+An Act relating to health insurance; amending 36 O.S.
44+2021, Section 6060.2 as amended by Section 1, Chapter
45+199, O.S.L. 2022 (36 O.S. Supp. 2022, Section
46+6060.2), which relates to the treatment of diabetes;
47+defining terms; directing the Insura nce Department
48+and the State Department of Health to purchase
49+insulin at discounted prices; creating a program that
50+allows Oklahomans to purchase discounted insulin;
51+providing for codification ; and providing an
52+effective date.
4353
4454
4555
4656
4757 BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHO MA:
48-SECTION 1. NEW LAW A new section of law to be codified
49-in the Oklahoma Statutes as Section 6060.2a of Title 36, unless
50-there is created a duplication in numbering, reads as follows:
51-A. The State shall direct the creation of a discount progr am
52-that will allow participants t o purchase insulin at a discounted,
53-post-rebate rate.
54-B. As used in this section , unless the context otherwise
55-requires:
56-1. "Participant" means a resident of Oklahoma who:
57-a. uses insulin to treat diabetes,
58-b. does not receive health coverage un der the program,
59-and
58+SECTION 1. AMENDATORY 36 O.S. 2021, Section 6060.2, as
59+amended by Section 1, Chapter 199 , O.S.L. 2022 (36 O.S. Supp. 2022,
60+Section 6060.2), is amended to read as follows :
61+Section 6060.2 A. 1. Every health benefit plan issued or
62+renewed on or after November 1, 1996, s hall, subject to the terms of
63+the policy contract or agreement, i nclude coverage for the following
64+equipment, supplies and related services for th e treatment of Type
65+I, Type II, and gestational diabetes, when medic ally necessary and
66+when recommended or pre scribed by a physician or other l icensed
6067
61-ENGR. H. B. NO. 2351 Page 2 1
68+HB2351 HFLR Page 2
69+BOLD FACE denotes Committee Amen dments. 1
6270 2
6371 3
6472 4
6573 5
6674 6
6775 7
6876 8
6977 9
7078 10
7179 11
7280 12
7381 13
7482 14
7583 15
7684 16
7785 17
7886 18
7987 19
8088 20
8189 21
8290 22
8391 23
8492 24
8593
86-c. enrolls in the discount program;
87-2. "Discount program" means a process developed by the program
88-that allows participants to purchase insulin at a discounted, post-
89-rebate rate;
90-3. "Rebate" means a refund, discount, or other price concession
91-that is paid by a pharmaceutica l manufacturer to a pharmacy benefit
92-manager based on a prescription drug's utilization or effectiveness.
93-Rebate does not include an admi nistrative fee.
94-C. For the purpose of the insulin discount program only, the
95-program shall allow participants to purchase insul in at a
96-discounted, post-rebate rate.
97-D. The discount program described in this section shall:
98-1. Provide a participant with a n electronic document that
99-identifies the participant as eligible for the discount;
100-2. Provide a participant with information a bout pharmacies that
101-will honor the discount;
102-3. Allow a participant to purchase insulin at a discounted,
103-post-rebate rate; and
104-4. Provide a participant with instructions to pursue a
105-reimbursement of the purchase price from the participant 's health
106-insurer.
107-E. The discount program shall charge a p rice for the insulin
108-that allows the program to retain only enough of any rebate fo r the
94+health care provider leg ally authorized to prescribe under the laws
95+of this state:
96+a. blood glucose monitors,
97+b. blood glucose monitors to the legally blind,
98+c. test strips for glucose monitors,
99+d. visual reading and urine testing strips,
100+e. insulin,
101+f. injection aids,
102+g. cartridges for the legally blind,
103+h. syringes,
104+i. insulin pumps and appurtenances theret o,
105+j. insulin infusion devices,
106+k. oral agents for controlling blood sugar, and
107+l. podiatric appliances for pr evention of complications
108+associated with diabetes.
109+2. The State Board of Health shall develop and annually update,
110+by rule, a list of additional diabetes equipment, related supplies
111+and health care provider servi ces that are medically necessary for
112+the treatment of diabetes, for which c overage shall also be
113+included, subject to the terms of the policy, contract, or
114+agreement, if the equipment and supplies have been approved by the
115+federal Food and Drug Administrat ion (FDA). Additional FDA-approved
116+diabetes equipment and related supplies , and health care provider
117+services shall be determined in consultation with a national
109118
110-ENGR. H. B. NO. 2351 Page 3 1
119+HB2351 HFLR Page 3
120+BOLD FACE denotes Committee Amen dments. 1
111121 2
112122 3
113123 4
114124 5
115125 6
116126 7
117127 8
118128 9
119129 10
120130 11
121131 12
122132 13
123133 14
124134 15
125135 16
126136 17
127137 18
128138 19
129139 20
130140 21
131141 22
132142 23
133143 24
134144
145+diabetes association affi liated with this state, and at least three
146+(3) medical directors of health benefit plans, to be selected by th e
147+State Department of Health.
148+3. All policies specified in this section shall also include
149+coverage for:
150+a. podiatric health care provider servic es as are deemed
151+medically necessary to prevent complications from
152+diabetes, and
153+b. diabetes self-management training. As used in this
154+subparagraph, "diabetes self-management training"
155+means instruction in an inpatient or outpatient
156+setting which enables diabetic patients to understand
157+the diabetic management process and daily management
158+of diabetic therapy as a method of avoiding frequent
159+hospitalizations and complications. Diabetes self-
160+management training shall comply with standards
161+developed by the State Board of Health in consultation
162+with a national diabetes associa tion affiliated with
163+this state and at lea st three medical directors of
164+health benefit plans selected by th e State Department
165+of Health. Coverage for diabetes self-management
166+training, including medical nutrition therapy relating
167+to diet, caloric intake, and diabetes management, but
168+
169+HB2351 HFLR Page 4
170+BOLD FACE denotes Committee Amen dments. 1
171+2
172+3
173+4
174+5
175+6
176+7
177+8
178+9
179+10
180+11
181+12
182+13
183+14
184+15
185+16
186+17
187+18
188+19
189+20
190+21
191+22
192+23
193+24
194+
195+excluding programs the only purpose of which a re
196+weight reduction, shall be li mited to the following:
197+(1) visits medically necessary upon the diagnosis of
198+diabetes,
199+(2) a physician diagnosis which represents a
200+significant change in the symptoms or condition
201+of the patient making medically necessary ch anges
202+in the self-management of the patient, and
203+(3) visits when reeducation or refresher training is
204+medically necessary;
205+provided, however, payment for the coverage required for d iabetes
206+self-management training pursuant to the provisions of this section
207+shall be required only upon cer tification by the health care
208+provider providing the training that the patient ha s successfully
209+completed diabetes self -management training.
210+4. Diabetes self-management training shall be sup ervised by a
211+licensed physician o r other licensed health care pr ovider legally
212+authorized to prescribe under the laws of this state. Diabetes
213+self-management training may be provided by the physician or other
214+appropriately registered, certified, or licens ed health care
215+professional as part of an office visit for diabe tes diagnosis or
216+treatment. Training provided by appropriately registered,
217+certified, or licensed health care professionals may be provided in
218+group settings where practicable.
219+
220+HB2351 HFLR Page 5
221+BOLD FACE denotes Committee Amen dments. 1
222+2
223+3
224+4
225+5
226+6
227+7
228+8
229+9
230+10
231+11
232+12
233+13
234+14
235+15
236+16
237+17
238+18
239+19
240+20
241+21
242+22
243+23
244+24
245+
246+5. Coverage for diabetes self-management training and training
247+related to medical nutrition therapy, when provided by a registered,
248+certified, or licensed heal th care professional, shall also include
249+home visits when medically necessary and shall include instruction
250+in medical nutrition therapy only b y a licensed registered dietic ian
251+or licensed certified nutritionist when authorized by the
252+supervising physician of the patient when medically necessary.
253+6. Coverage may be subjec t to the same annual deductibles or
254+coinsurance as may be deemed appropriat e and as are consistent with
255+those established for other covered benefits within a given policy.
256+7. Any health benefit plan, as defined pursuant to Section
257+6060.4 of this title, that provides coverage for insulin pursuant to
258+this section shall cap the t otal amount that a cov ered person is
259+required to pay for insulin at an amount not to exceed Thirty
260+Dollars ($30.00) per thirty-day supply or Ninety Dollars ($90.00)
261+per ninety-day supply of insulin for each covered insulin
262+prescription, regardless of the a mount or type of insul in needed to
263+fill the prescription or prescriptions of the covered person.
264+a. Nothing in this paragraph shall prev ent a health
265+benefit plan from reducing the cos t-sharing of a
266+covered person to an amount less than Thirty Dolla rs
267+($30.00) per thirty-day supply or Ninety Dollars
268+($90.00) per ninety-day supply.
269+
270+HB2351 HFLR Page 6
271+BOLD FACE denotes Committee Amen dments. 1
272+2
273+3
274+4
275+5
276+6
277+7
278+8
279+9
280+10
281+11
282+12
283+13
284+14
285+15
286+16
287+17
288+18
289+19
290+20
291+21
292+22
293+23
294+24
295+
296+b. The Insurance Commissioner shall ens ure all health
297+benefit plans comply with the requirements of this
298+paragraph.
299+c. The Commissioner may promulgat e rules as necessary to
300+implement and administer the requirements of this
301+paragraph and to align with federal requirements.
302+B. 1. Health benefit plans shall not reduce or eliminate
303+coverage due to the requirement s of this section.
304+2. Enforcement of the provisions of this act shall be performed
305+by the Insurance Department and the State Department of Health.
306+C. As used in this section, "health benefit plan" means any
307+plan or arrangement as d efined in subsection C of Section 6060.4 of
308+this title.
309+SECTION 2. NEW LAW A new section of law to be codified
310+in the Oklahoma Statutes as Section 6060.2a of Title 36, unless
311+there is created a duplication in numbering, reads as follows:
312+A. The State shall direct the creation of a discount progr am
313+that will allow participants t o purchase insulin at a discounted,
314+post-rebate rate.
315+B. As used in this section , unless the context otherwise
316+requires:
317+1. "Participant" means a resident of Oklahoma who:
318+a. uses insulin to treat diabetes,
319+
320+HB2351 HFLR Page 7
321+BOLD FACE denotes Committee Amen dments. 1
322+2
323+3
324+4
325+5
326+6
327+7
328+8
329+9
330+10
331+11
332+12
333+13
334+14
335+15
336+16
337+17
338+18
339+19
340+20
341+21
342+22
343+23
344+24
345+
346+b. does not receive health coverage un der the program,
347+and
348+c. enrolls in the discount program;
349+2. "Discount program" means a process developed by the program
350+that allows participants to purchase insulin at a discounted, post -
351+rebate rate;
352+3. "Rebate" means a refund, discount or other price concession
353+that is paid by a pharmaceutica l manufacturer to a pharmacy benefit
354+manager based on a prescription drug's utilization or effectiveness.
355+"Rebate" does not include an administrative fee.
356+C. For the purpose of the insulin discount program only, the
357+program shall allow participants to purchase insul in at a
358+discounted, post-rebate rate.
359+D. The discount program described in this section shall:
360+1. Provide a participant with an electroni c document that
361+identifies the participant as eligible for the discount;
362+2. Provide a participant with information a bout pharmacies that
363+will honor the discount;
364+3. Allow a participant to purchase insulin at a discounted,
365+post-rebate rate; and
366+4. Provide a participant with instructions to pursue a
367+reimbursement of the purchase price from the participant 's health
368+insurer.
369+
370+HB2351 HFLR Page 8
371+BOLD FACE denotes Committee Amen dments. 1
372+2
373+3
374+4
375+5
376+6
377+7
378+8
379+9
380+10
381+11
382+12
383+13
384+14
385+15
386+16
387+17
388+18
389+19
390+20
391+21
392+22
393+23
394+24
395+
396+E. The discount program shall charge a p rice for the insulin
397+that allows the program to retain only enough of any rebate for the
135398 insulin to make the state risk pool whole for providing discounted
136399 insulin to participants.
137-SECTION 2. This act shall become effective November 1, 2023.
138-Passed the House of Representatives the 14th day of March, 2023.
400+SECTION 3. This act shall become effective November 1, 2023.
139401
140-
141-
142-
143- Presiding Officer of the House
144- of Representatives
145-
146-
147-
148-Passed the Senate the ____ day of __________, 2023.
149-
150-
151-
152-
153- Presiding Officer of the Senate
154-
155-
402+COMMITTEE REPORT BY: COMMITTEE ON INSURANCE, dated 02/28/2023 - DO
403+PASS.